Abstract:Osteosarcoma (OS) is the most frequent malignant primary bone tumor in children and young adults. Zinc finger Asp-His-His-Cys palmitoyl-acyltransferase 19 (ZDHHC19) is a key enzyme in protein palmitoylation and plays crucial roles in tumor progression. However, its expression profile and biological function in OS have been unclear. In the present study, the expression level of ZDHHC19 in OS cell lines was determined by qRT-PCR and Western blot. The effect of ZDHHC19 in cell growth, invasion and migration was analyzed by CCK8, EDU, transwell, wound healing assay in vitro, and xenograft tumor model in vivo. In addition, bioinformatics analysis was used to explore the potential mechanism of ZDHHC19 in OS. Furthermore, the luciferase reporter assay was conducted to determine the direct binding between miR-940 and ZDHHC19. We discovered that ZDHHC19 was overexpressed in OS cells compared with the normal cells. The functional investigation demonstrated that ZDHHC19 silencing could inhibit proliferation, invasion and migration of OS in vitro and suppress tumorigenicity and lung metastasis in a xenograft model in vivo. Mechanistically, we identified that ZDHHC19 was a direct target of miR-940 and forced ZDHHC19 expressions partially rescue the suppression of proliferation, migration and invasion induced by miR-940. Moreover, bioinformatics analysis combined with validation experiments revealed that activating wnt/β-catenin pathway contributed to the pro-oncogenic effect induced by ZDHHC19. Furthermore, rescue experiments further verified that miR-940/ZDHHC19 axis regulated wnt/β-catenin pathway. Overall, these findings indicated that miR-940/ZDHHC19 axis played a significant role in OS progression and might be considered as a novel target for OS treatment.Abbreviations: OS, osteosarcoma; miRNAs, microRNAs; 3'-UTR, 3'- untranslated region; TARGET, Therapeutically Applicable Research To Generate Effective Treatments; qRT-PCR, quantitative real-time PCR; IHC, Immunohistochemistry; GSVA, Gene Set Variation Analysis; GSEA, Gene Set Enrichment Analysis; KEGG, Kyoto Encyclopedia of Genes and Genomes.

Silencing Ubc9 Expression Suppresses Osteosarcoma Tumorigenesis and Enhances Chemosensitivity to HSV-TK/GCV by Regulating Connexin 43 SUMOylation.

Zinc finger Asp-His-His-Cys palmitoyl -acyltransferase 19 accelerates tumor progression through wnt/β-catenin pathway and is upregulated by miR-940 in osteosarcoma

Overexpression of SENP1 Reduces the Stemness Capacity of Osteosarcoma Stem Cells and Increases Their Sensitivity to HSVtk/GCV

Connexin 43 SUMOylation Improves Gap Junction Functions Between Liver Cancer Stem Cells and Enhances Their Sensitivity to HSVtk/GCV.

Epigenetic Regulation of CXCL12 Plays a Critical Role in Mediating Tumor Progression and the Immune Response in Osteosarcoma

Knockdown of Ubiquitin-Specific Peptidase 39 Inhibited the Growth of Osteosarcoma Cells and Induced Apoptosis in Vitro.

Repression of the SUMO-conjugating enzyme UBC9 is associated with lowered double minutes and reduced tumor progression

Silencing of Synaptotagmin 7 Regulates Osteosarcoma Cell Proliferation, Apoptosis, and Migration.

Identification of Tumorigenicity-Associated Genes in Osteosarcoma Cell Lines Based on Bioinformatic Analysis and Experimental Validation.

Association Between SOX9 and CA9 in Glioma, and Its Effects on Chemosensitivity to TMZ.

CYC1 Silencing Sensitizes Osteosarcoma Cells to TRAIL-induced Apoptosis.

Heterogeneous Expression and Biological Function of Ubiquitin Carboxy-Terminal Hydrolase-L1 in Osteosarcoma

NUCB2 Inhibition Antagonizes Osteosarcoma Progression and Promotes Anti-Tumor Immunity through Inactivating NUCKS1/CXCL8 Axis

MiR-34a and Mir-203 Inhibit Survivin Expression to Control Cell Proliferation and Survival in Human Osteosarcoma Cells

[Desumoylation of Protein Kinase B1 Inhibits Cell Proliferation and Metastasis of Hepatocellular Carcinoma].

Silencing of HuR Inhibits Osteosarcoma Cell Epithelial-Mesenchymal Transition via AGO2 in Association With Long Non-Coding RNA XIST

SUMO-1 Gene Silencing Inhibits Proliferation and Promotes Apoptosis of Human Gastric Cancer SGC-7901 Cells

Effects of combined c-myc and Bmi-1 siRNAs on the growth and chemosensitivity of MG-63 osteosarcoma cells.

Ubiquitination in osteosarcoma: unveiling the impact on cell biology and therapeutic strategies

Targeting USP9x/SOX2 Axis Contributes to the Anti-Osteosarcoma Effect of Neogambogic Acid.

CXCR1 Knockdown Improves the Sensitivity of Osteosarcoma to Cisplatin